It inhibits VEGF signaling, thereby downregulating the proliferation, migration, and angiogenesis of hepatocellular carcinoma cells and thus significantly prolonging HCC patient overall survival [16]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.